MedPath
NMPA Approval

Naltrexone Hydrochloride Implants

国药准字H20240031

June 25, 2024

Drug Information

盐酸纳曲酮植入剂

植入剂

0.15g(以C₂₀H₂₃NO₄计)

化学药品

June 25, 2024

Company Information

Applicant Company

深圳市坪山区龙田街道竹坑社区长方照明工业厂区厂房C-2101

Manufacturing Company

深圳市坪山区龙田街道竹坑社区长方照明工业厂区厂房C2栋

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸纳曲酮植入剂 - NMPA 批准文号 | MedPath